FDA approves Codman’s MEDSTREAM Programmable Infusion System
20:20 EDT 8 Aug 2012 | The Medical News
Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and cathete..
Original Article: FDA approves Codman’s MEDSTREAM Programmable Infusion System
More From BioPortfolio on "FDA approves Codman’s MEDSTREAM Programmable Infusion System"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
